Stock Events

Stock Events

Kiromic BioPharma 

$0.000100
0
+$0.00+0% Wednesday 20:00

Statistics

Day High
0.005
Day Low
0.005
52W High
0.005
52W Low
0.00001
Volume
10,000
Avg. Volume
1
Mkt Cap
153.3
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

14AugExpected
Q3 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Q1 2026
Q2 2026
999
333
-333
-999
Expected EPS
N/A
Actual EPS
N/A

Financials

-Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
0Revenue
-26.9MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow KRBPQ. It's not an investment recommendation.
Apple
3
AAPL
Microsoft
3
MSFT
AMD
3
AMD
Tesla
2
TSLA

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
CRISPR Therapeutics
CRSP
Mkt Cap5.58B
CRISPR Therapeutics is involved in gene editing, a similar innovative technology space as Kiromic BioPharma's gene therapy approaches.
Editas Medicine
EDIT
Mkt Cap485.31M
Editas Medicine operates in the CRISPR gene editing sector, directly competing with Kiromic BioPharma's gene therapy and editing technologies.
Intellia Therapeutics
NTLA
Mkt Cap1.8B
Intellia Therapeutics is a leading developer of CRISPR gene editing therapies, competing in the same innovative treatment space as Kiromic BioPharma.
Allogene Therapeutics
ALLO
Mkt Cap697.89M
Allogene Therapeutics is focused on allogeneic CAR T cell therapies, a direct competitor to Kiromic BioPharma's cell therapy approaches.
Gilead Sciences
GILD
Mkt Cap180.64B
Gilead Sciences, through its acquisition of Kite Pharma, competes in the cell therapy space for cancer, similar to Kiromic BioPharma's focus.
Biomarin Pharmaceutical
BMRN
Mkt Cap12.52B
BioMarin Pharmaceutical develops gene therapies for rare genetic diseases, indirectly competing with Kiromic BioPharma's gene therapy efforts.
Pfizer
PFE
Mkt Cap159.36B
Pfizer, with its investments in gene therapy and CRISPR technology, competes across a broad range of therapeutic areas including those targeted by Kiromic BioPharma.

About

KIROMIC BIOPHARMA INC
Show more...
CEO
Mr. Pietro Bersani CPA, J.D.
Country
United States
ISIN
US4976342042
WKN
000A3D7BN

Listings

MU
DE
5JU.MU
OTC Link
US
KRBPQ
STU
DE
5JU.STU
MU
DE
5JU0.MU

0 Comments

Share your thoughts

FAQ

What is Kiromic BioPharma stock price today?▼
The current price of KRBPQ is $0.00 USD — it has increased by +0% in the past 24 hours. Watch Kiromic BioPharma stock price performance more closely on the chart.
What is Kiromic BioPharma stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange Kiromic BioPharma stocks are traded under the ticker KRBPQ.
Is Kiromic BioPharma stock price growing?▼
KRBPQ stock has risen by +0% compared to the previous week, the month change is a +0% rise, over the last year Kiromic BioPharma has showed a -97.5% decrease.
What is Kiromic BioPharma market cap?▼
Today Kiromic BioPharma has the market capitalization of 153.3
What is Kiromic BioPharma revenue for the last year?▼
Kiromic BioPharma revenue for the last year amounts to 0 USD.
What is Kiromic BioPharma net income for the last year?▼
KRBPQ net income for the last year is -26.9M USD.
In which sector is Kiromic BioPharma located?▼
Kiromic BioPharma operates in the Other sector.
When did Kiromic BioPharma complete a stock split?▼
The last stock split for Kiromic BioPharma was on March 13, 2023 with a ratio of 1:30.
Where is Kiromic BioPharma headquartered?▼
Kiromic BioPharma is headquartered in Houston, United States.